{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:13:58Z","timestamp":1713744838108},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,20]]},"DOI":"10.7759\/cureus.58651","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:46:25Z","timestamp":1713667585000},"source":"Crossref","is-referenced-by-count":0,"title":["Case of Immune Checkpoint Inhibitor Induced Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Manoja","family":"Gullapalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narenraj","family":"Arulprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin","family":"Safar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Kocurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666201230151224","article-title":"Immune checkpoint inhibitors and neurotoxicity","volume":"19","author":"Zhao Z","year":"2021","unstructured":"Zhao Z, Zhang C, Zhou L, Dong P, Shi L. Immune checkpoint inhibitors and neurotoxicity. Curr Neuropharmacol. 2021, 19:1246-63. 10.2174\/1570159X19666201230151224","journal-title":"Curr Neuropharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4110\/in.2020.20.e9","article-title":"Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors","volume":"20","author":"Choi J","year":"2020","unstructured":"Choi J, Lee SY. Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors. Immune Netw. 2020, 20:e9. 10.4110\/in.2020.20.e9","journal-title":"Immune Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow MA","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018, 378:158-68. 10.1056\/NEJMra1703481","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez418","article-title":"Toxicities associated with checkpoint inhibitors-an overview","volume":"58","author":"Spiers L","year":"2019","unstructured":"Spiers L, Coupe N, Payne M. Toxicities associated with checkpoint inhibitors-an overview. Rheumatology (Oxford). 2019, 58:vii7-vii16. 10.1093\/rheumatology\/kez418","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa051","article-title":"Checkpoint inhibitor-induced myocarditis and myasthenia gravis in a recurrent\/metastatic thymic carcinoma patient: a case report","volume":"4","author":"Szuchan C","year":"2020","unstructured":"Szuchan C, Elson L, Alley E, et al.. Checkpoint inhibitor-induced myocarditis and myasthenia gravis in a recurrent\/metastatic thymic carcinoma patient: a case report. Eur Heart J Case Rep. 2020, 4:1-8. 10.1093\/ehjcr\/ytaa051","journal-title":"Eur Heart J Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5126717","article-title":"The terrible triad of checkpoint inhibition: a case report of myasthenia gravis, myocarditis, and myositis induced by cemiplimab in a patient with metastatic cutaneous squamous cell carcinoma","volume":"2020","author":"Jeyakumar N","year":"2020","unstructured":"Jeyakumar N, Etchegaray M, Henry J, Lelenwa L, Zhao B, Segura A, Buja LMu. The terrible triad of checkpoint inhibition: a case report of myasthenia gravis, myocarditis, and myositis induced by cemiplimab in a patient with metastatic cutaneous squamous cell carcinoma. Case Reports Immunol. 2020, 2020:5126717. 10.1155\/2020\/5126717","journal-title":"Case Reports Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00634","article-title":"Immune checkpoint inhibitor-induced myasthenia gravis","volume":"11","author":"Huang YT","year":"2020","unstructured":"Huang YT, Chen YP, Lin WC, Su WC, Sun YT. Immune checkpoint inhibitor-induced myasthenia gravis. Front Neurol. 2020, 11:634. 10.3389\/fneur.2020.00634","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0774-y","article-title":"Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature","volume":"7","author":"Safa H","year":"2019","unstructured":"Safa H, Johnson DH, Trinh VA, et al.. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. J Immunother Cancer. 2019, 7:319. 10.1186\/s40425-019-0774-y","journal-title":"J Immunother Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15174","article-title":"Pembrolizumab-associated seronegative myasthenia gravis in a patient with metastatic renal cell carcinoma","volume":"13","author":"Pandya SK","year":"2021","unstructured":"Pandya SK, Ulrickson M, Dong J, Willen R, Pandya A. Pembrolizumab-associated seronegative myasthenia gravis in a patient with metastatic renal cell carcinoma. Cureus. 2021, 13:e15174. 10.7759\/cureus.15174","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99168-case-of-immune-checkpoint-inhibitor-induced-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:46:28Z","timestamp":1713667588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99168-case-of-immune-checkpoint-inhibitor-induced-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.58651","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,20]]}}}